Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 5Sleep Apnea, Obstructive 2Breast Neoplasms 2Sleep Apnea Syndromes 1Osteoporosis 1Obesity 1Myocardial Ischemia 1Metabolic Syndrome 1Insulin Resistance 1Hyperandrogenism 1Heart Diseases 1Glucose Intolerance 1Estrogen Receptor Positive Breast Cancer 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Bone Diseases 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Estrogens × Clear all
NCT05562518 2026-04-30

GRACE

University Hospital, Ghent

Phase 4 Active not recruiting
160 enrolled
Breast

Breast Neoplasms

NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡